Did you mean: D. E. Zomer-van Ommen

Long‐term expanding human airway organoids for disease modeling

…, A Papaspyropoulos, DD Zomervan Ommen… - The EMBO …, 2019 - embopress.org
Organoids are self‐organizing 3D structures grown from stem cells that recapitulate essential
aspects of organ structure and function. Here, we describe a method to establish long‐term…

[HTML][HTML] Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids

DD Zomer-van Ommen, LAW Vijftigschild… - Journal of Cystic …, 2016 - Elsevier
Premature termination codon read-through drugs offer opportunities for treatment of multiple
rare genetic diseases including cystic fibrosis. We here analyzed the read-through efficacy …

[HTML][HTML] Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression

…, R Vries, DD Zomer-van Ommen… - European …, 2022 - Eur Respiratory Soc
… Vries and DD Zomer-van Ommen contributed to the acquisition of study data and revised
the manuscript. MJC Eijkemans contributed to the design of the study, analysis and …

Functional characterization of cholera toxin inhibitors using human intestinal organoids

DD Zomer-van Ommen, AV Pukin, O Fu… - Journal of Medicinal …, 2016 - ACS Publications
Preclinical drug testing in primary human cell models that recapitulate disease can significantly
reduce animal experimentation and time-to-the-clinic. We used intestinal organoids to …

[HTML][HTML] Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity

DD Zomer-van Ommen, E de Poel, E Kruisselbrink… - Journal of Cystic …, 2018 - Elsevier
Background New functional assays using primary human intestinal adult stem cell cultures
can be valuable tools to study epithelial defects in human diseases such as cystic fibrosis. …

β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis

…, JF Dekkers, DD Zomer-van Ommen… - European …, 2016 - Eur Respiratory Soc
We hypothesized that people with cystic fibrosis (CF) who express CFTR (cystic fibrosis
transmembrane conductance regulator) gene mutations associated with residual function may …

[HTML][HTML] Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective …

…, BM Faber-Bisschop, DD Zomer-van Ommen… - …, 2023 - thelancet.com
Zomer-van Ommen reviewed the manuscript on behalf of the NCFS. The NCFS and Health
… Administrative, technical or material support: DD Zomer-van Ommen. Supervision: CK van …

[HTML][HTML] Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis

D Muilwijk, DD Zomer-van Ommen… - ERJ Open …, 2022 - Eur Respiratory Soc
… Muilwijk and MJC Eijkemans; resources: DD Zomer-van Ommen and VAM … , DD Zomer-van
Ommen and CK van der Ent; writing (review and editing): D. Muilwijk, DD Zomer-van Ommen

Optimization of performance of Dutch newborn screening for cystic fibrosis

…, RK Verschoof-Puite, DD Zomer-van Ommen… - Journal of cystic …, 2024 - Elsevier
Background Dutch newborn screening (NBS) for Cystic Fibrosis (CF) introduced in 2011
showed a sensitivity of 90% and a positive predictive value (PPV) of 63%. We describe a study …

P152 Development and validation of a personalised electronic patient-reported outcome measure to assess individual quality of life

…, DD Zomer-van Ommen… - Journal of Cystic …, 2023 - cysticfibrosisjournal.com
Objectives To develop and validate a personalized patient-reported outcome measure (PROM)
that enables a systematic assessment of the impact of care and treatment modalities on …
Did you mean to search for: D. E. Zomer-van Ommen